References
- Espinel-Ingroff A, Fothergill A, Ghannoum M, Manavathu E, Ostrosky-Zeichner L, Pfaller MA, Rinaldi MG, Schell W, Walsh TJ. Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds. J Clin Microbiol. 2007. 45: 2180-2182. https://doi.org/10.1128/JCM.00399-07
- Foldi R, Szilagyi J, Kardos G, Berenyi R, Kovacs R, Majoros L. Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time-kill methodology. Diagn Microbiol Infect Dis. 2012. 73: 338-342. https://doi.org/10.1016/j.diagmicrobio.2012.05.011
- Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidasis in a neonatal intensive care unit. J Pediatr. 2005. 147: 166-171. https://doi.org/10.1016/j.jpeds.2005.04.016
- Kanafani ZA, Perfect JR. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis. 2008. 46: 120-128. https://doi.org/10.1086/524071
- Odabasi Z, Paetznick V, Rex JH, Ostrosky-Zeichner L. Effects of serum on in vitro susceptibility testing of echomocandins. Antimicrob Agents Chemother. 2007. 51: 4214-4216. https://doi.org/10.1128/AAC.01589-06
- Park SD, Uh Y, Jang IH, Yoon KJ, Shin JH. Comparison of ATB FUNGUS 2 and VITEK-2 antifungal susceptibility (ASTYS01) tests for Candida species isolated from blood culture. Korean J Clin Microbiol. 2010. 13: 114-120. https://doi.org/10.5145/KJCM.2010.13.3.114
- Pfaller MA, Grant C, Morthland V, Rhine Chalberg J. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J Clin Microbiol. 1994. 32: 506-509.
- Pfaller MA, Messer SA, Coffmann S. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using microdilution methods to test five antifungal agents, including the new triazole. J Clin Microbial. 1995. 33: 1094-1097.
- Pfaller MA. Nosocomial candidiasis: emerging species, reservoirs and modes of transmission. Clin Infect Dis. 1996. 22: 89-94. https://doi.org/10.1093/clinids/22.Supplement_2.S89
- Pfaller MA, Rex JH, Rinaldi MG. Antifungal susceptibility testing: technical advances and potential clinical applications. Clin Infect Dis. 1997. 24: 766-784.
- Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, Gosey LL, Odds FC, Rinaldi MG, Sheehan DJ, Warnock DW. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbial Rev. 2001. 14: 643-658. https://doi.org/10.1128/CMR.14.4.643-658.2001
- Rex JH, Alexander BD, Andes D, Arthington-Skaggs B, Brown SD, Chaturvedi V, Ghannoum MA, Espinel-Igroff A, Knapp CC, Ostrosky-Zeichner L, Pfaller MA, Sheehan DJ, Walsh TJ. Reference method for broth dilution antifungal susceptibility testing of yeasts. CLSI. 2008.
- Shin JH, Lim WH, Shin DH, Suh SP, Ryang DW. Candida species isolated from clinical specimens and medical personnel. Korean J Infect Dis. 1999. 31: 481-486.
- Tiballi RN, He X, Zarins LT, Revankar SG, Kauffman CA. Use of a colorimetric system for yeast susceptibility testing. J Clin Microbio. 1995. 33: 915-917.
- To WK, Fothergill AW, Rinaldi MG. Comparative evaluation of macrodilution and Alamar colormetric microdilution broth methods for antifungal susceptibility testing of yeast isolates. J Clin Microbiol. 1995. 33: 2660-2664.
- Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 2004. 351: 1391-1402. https://doi.org/10.1056/NEJMoa040446
- White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbial Rev. 1998. 11: 382-402.